FDA Grants No Labeling Privileges To “Convenience-Size” Cosmetic-Drugs
This article was originally published in The Rose Sheet
Executive Summary
FDA's proposed rule on labeling requirements for over-the-counter drug products does not address CTFA's repeated contention that "convenience-size" items earmarked for exemptions should include topical OTC drugs with no dosage limitations